A Cymbalta class action may include victims injured by the effects of this dangerous anti-depressant responsible for the suicidality and discontinuation symptoms that have plagued many Americans. Cymbalta is a popular SSRI anti-depressant drug that, when ceased, can wreak havoc on the user’s physical and emotional health. Cymbalta users between the ages of 18-24 are at a particularly high risk of developing suicidal thoughts and tendencies while taking Cymbalta and upon discontinuation.
Cymbalta is a selective serotonin reuptake inhibitor (SSRI) that works to regulate serotonin levels in the brain. Serotonin is responsible for mood and personality and imbalances in this chemical can lead to conditions like generalized anxiety disorder (GAD), major depression disorder (MDD), fibromyalgia and diabetic neuropathy. While many patients have responded well to this treatment, thousands of patients reported a range of symptoms upon discontinuation of this drug.
Discontinuation symptoms are similar to withdrawal and include may milder physical symptoms like nausea and fatigue as well as severe symptoms like dizziness, seizures, vertigo, emotional disturbances and mood swings. Eli Lilly, the manufacturer of Cymbalta, does not warn consumers of the increased risk of withdrawal and many are surprised upon discontinuation of the drug.
Class action lawsuits are unique in that they join together plaintiffs from multiple jurisdictions who are suffering identical injuries. Class actions must be certified by a judge to ensure that the plaintiffs are all suffering the same injury at the hands of the same defendant or cause. The purpose of this certification is to ensure that the eventual jury award will redress each plaintiff’s injuries. Cymbalta class actions are forming as plaintiffs across the nation are beginning to commence their claims.
If you are interested in joining a Cymbalta class action, we encourage you to contact us as soon as possible. We are a professional law corporation dedicated to the advocacy and representation of clients facing injuries as a result of the dangerous drug Cymbalta.